Evidence map›Paper›PMID 33164986›Full record

ArticleThe Journal of clinical investigation2020

YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress.

Elisa De Franco, Maria Lytrivi, Hazem Ibrahim, Hossam Montaser, Matthew N Wakeling, Federica Fantuzzi, Kashyap Patel, Céline Demarez, Ying Cai, Mariana Igoillo-Esteve and 29 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Coordinated expression and assembly of BiP, p58Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. From bats to humans: uncoveringbioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Neonatal diabetes mellitus is a significant feature of COXPD-24 caused by recessive NARS2 variants.Diabetic medicine : a journal of the British Diabetic Association · 2025
    Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Neonatal diabetes mellitus around the world: Update 2024.Journal of diabetes investigation · 2024
    Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

39 authors at 13 institutions in 9 countries.

Elisa De FrancoInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
Maria LytriviULB Center for Diabetes Research and.
Hazem IbrahimStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Hossam MontaserStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Matthew N WakelingInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
Federica FantuzziULB Center for Diabetes Research and.
Kashyap PatelInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
Céline DemarezULB Center for Diabetes Research and.
Ying CaiULB Center for Diabetes Research and.
Mariana Igoillo-EsteveULB Center for Diabetes Research and.
Cristina CosentinoULB Center for Diabetes Research and.
Väinö LithoviusStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Helena VihinenElectron Microscopy Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Eija JokitaloElectron Microscopy Unit, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.
Thomas W LaverInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
Matthew B JohnsonInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
Toshiaki SawataniULB Center for Diabetes Research and.
Hadis ShakeriULB Center for Diabetes Research and.
Nathalie PacheraULB Center for Diabetes Research and.
Belma HalilogluYeditepe University Hospital, Istanbul, Turkey.
Mehmet Nuri OzbekGazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey.
Edip UnalDicle University, Faculty of Medicine, Department of Pediatric Endocrinology, Diyarbakır, Turkey.
Ruken YıldırımDicle University, Faculty of Medicine, Department of Pediatric Endocrinology, Diyarbakır, Turkey.
Tushar GodboleHarmony Health Hub, Nashik, India.
Melek YildizIstanbul University, Istanbul Faculty of Medicine, Department of Pediatric Endocrinology, Istanbul, Turkey.
Banu AydinKanuni Sultan Suleyman Training and Research Hospital, Department of Pediatric Endocrinology, Istanbul, Turkey.
Angeline BilheuInstitute of Interdisciplinary Research (IRIBHM), ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium.
Ikuo SuzukiInstitute of Interdisciplinary Research (IRIBHM), ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium.
Sarah E FlanaganInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
Pierre VanderhaeghenInstitute of Interdisciplinary Research (IRIBHM), ULB Neuroscience Institute, Université Libre de Bruxelles, Brussels, Belgium.
Valérie SenéeUniversité de Paris, Faculté de Médecine Paris-Diderot, U958, Paris, France.
Cécile JulierUniversité de Paris, Faculté de Médecine Paris-Diderot, U958, Paris, France.
Piero MarchettiDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Decio L EizirikULB Center for Diabetes Research and.
Sian EllardInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
Jonna Saarimäki-VireStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Timo OtonkoskiStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Miriam CnopULB Center for Diabetes Research and.
Andrew T HattersleyInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, United Kingdom.
University of Exeter · GBGerman Center for Diabetes Research · DEUniversity of Helsinki · FIUniversité Libre de Bruxelles · BEDélégation Paris 7 · FRDicle University · TRDiyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi · TRİstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi · TRIstanbul University · TRMaharashtra University of Health Sciences · INUniversity of Parma · ITUniversity of Pisa · ITYeditepe University Hospital · TR

Funding

Department of HealthWellcome TrustWellcome Trust 105636/Z/14/ZWellcome Trust WT098395/Z/12/Z
6 · The paper itself

Abstract

Neonatal diabetes is caused by single gene mutations reducing pancreatic β cell number or impairing β cell function. Understanding the genetic basis of rare diabetes subtypes highlights fundamental biological processes in β cells. We identified 6 patients from 5 families with homozygous mutations in the YIPF5 gene, which is involved in trafficking between the endoplasmic reticulum (ER) and the Golgi. All patients had neonatal/early-onset diabetes, severe microcephaly, and epilepsy. YIPF5 is expressed during human brain development, in adult brain and pancreatic islets. We used 3 human β cell models (YIPF5 silencing in EndoC-βH1 cells, YIPF5 knockout and mutation knockin in embryonic stem cells, and patient-derived induced pluripotent stem cells) to investigate the mechanism through which YIPF5 loss of function affects β cells. Loss of YIPF5 function in stem cell-derived islet cells resulted in proinsulin retention in the ER, marked ER stress, and β cell failure. Partial YIPF5 silencing in EndoC-βH1 cells and a patient mutation in stem cells increased the β cell sensitivity to ER stress-induced apoptosis. We report recessive YIPF5 mutations as the genetic cause of a congenital syndrome of microcephaly, epilepsy, and neonatal/early-onset diabetes, highlighting a critical role of YIPF5 in β cells and neurons. We believe this is the first report of mutations disrupting the ER-to-Golgi trafficking, resulting in diabetes.

Indexed as

Diabetes MellitusGenetic Diseases, InbornInfant, Newborn, DiseasesMicrocephalyMutationVesicular Transport ProteinsCell LineEndoplasmic Reticulum StressFemaleHuman Embryonic Stem CellsHumansInduced Pluripotent Stem CellsInfant, NewbornInsulin-Secreting CellsMaleNeuronsVesicular Transport ProteinsYIPF5 protein, humanCell BiologyCell stressDiabetesGeneticsHuman stem cells

Identifiers

PMID33164986
PMCPMC7685733
OpenAlexW3082914373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.